Mentis Pharma Limited - Company Profile

It is a trading public limited company based in New Delhi, Delhi, India, established in 2002.
2002 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Mentis Pharma Limited

Mentis Pharma Limited, a active public limited company, was established on 05 November 2002 in New Delhi, Delhi, India. Engaging in wholesale within the trade sector, it holds CIN: U24239DL2002PLC117591. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Inder Neel Gandhi (Director), Sanjay Taneja (Director), Akshay Kumar (Additional Director). Past directors included Ashok Kumar Tyagi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-257 Ist Floornaraina Industrial Area Phase-I, New Delhi, Delhi, 110028.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239DL2002PLC117591

  • Registration Number

    117591

  • Incorporation Date

    05 November 2002

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 23 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Mentis Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mentis Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Mentis Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Inder Neel Gandhi Director 05 Nov 2002 Current
Sanjay Taneja Director 05 Nov 2002 Current
Akshay Kumar Additional Director 01 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mentis Pharma.

Mentis Pharma Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Mentis Pharma revenue growth over time
Mentis Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mentis Pharma?

In 2017, Mentis Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Mentis Pharma?

Unlock and access historical data on people associated with Mentis Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mentis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mentis Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mentis Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Akshay Kumar was appointed as a Additional Director was appointed as a Additional Director on 01 Aug 2025 & has been associated with this company since 6 months 7 days . was completed.

  • Annual General Meeting

    Mentis Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Mentis Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Inder Neel Gandhi was appointed as a Director was appointed as a Director on 05 Nov 2002 & has been associated with this company since 23 years 3 months . was completed.

  • Director Appointment

    The activity Sanjay Taneja was appointed as a Director was appointed as a Director on 05 Nov 2002 & has been associated with this company since 23 years 3 months . was completed.

  • Company Incorporation

    Mentis Pharma Limited was registered on 05 Nov 2002 with Roc Delhi & aged 23 years 3 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mentis Pharma Limited?

The CIN of Mentis Pharma Limited is U24239DL2002PLC117591.

Where is Mentis Pharma Limited headquartered?

Mentis Pharma Limited is headquartered at B-257 Ist Floornaraina Industrial Area Phase-I, New Delhi, Delhi, 110028.

When was Mentis Pharma Limited incorporated?

Mentis Pharma Limited was incorporated on 05 November 2002.

Who are the current directors of Mentis Pharma Limited?

The current directors of Mentis Pharma Limited are

What is the primary industry of Mentis Pharma Limited?

The primary industry of Mentis Pharma Limited is Trade.

Is Mentis Pharma Limited a listed company?

Mentis Pharma Limited is unlisted.

What is the capital structure of Mentis Pharma Limited?

The authorized capital of Mentis Pharma Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Mentis Pharma Limited?

The compliance status of Mentis Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available